Skip to content
HW210605 PREDiCT Tumour Models London logo

14 - 16 December, 2021
Digital Event, GMT

  • Home
  • About
    • About Event
    • About the PREDiCT Series
    • Content Hub
    • Testimonials
    • About Digital
    • FAQs
  • Programme
    • Full Event Guide
    • Speakers
    • Pre-Conference Workshop Day
    • Agenda
      • Day One
      • Day Two
  • Partnerships
    • Partnership Opportunities
    • Partners
    • Media Partners
    • PREDiCT Series Prospectus
  • Take Part
    • Register Interest
    • Contact us

OcellO

By digitalsystems | 8th October 2019

OcellO is an innovative biotech company offering CRO services for the drug discovery industry that can significantly improve the efficiency of lead development. OcellO excels in the development of clinically relevant in vitro human micro-tissue models that can be used for the screening and profiling of small molecules and biologics. The analysis of these models, many of which use patient-derived material, is enabled by OcellO’s unique high throughput 3D imaging and phenotypic profiling technology. As well as providing measurements of cell growth and viability, phenotypic profiling allows the measurement of more complex biology that better correlates with clinical endpoints. Furthermore, compounds with the optimum therapeutic profile or optimum target specific… www.ocello.nl

OUR CONTACT DETAILS

T: +44 (0)20 3141 8700
E: info@hansonwade.com

VENUE DETAILS

Digital Event

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

SEARCH

ORGANISED BY

HansonWade Logo

Terms & Conditions

Privacy Policy

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.